Sensei Biotherapeutics Inc. Files Initial Statement of Beneficial Ownership for President & PEO Christopher Gerry
Sensei Biotherapeutics Inc. has filed an initial statement of beneficial ownership with the SEC, listing Christopher Gerry as the beneficial owner and serving as President and PEO. This filing is accessible via the EDGAR system. The information is provided by Public Technologies (PUBT) and is for informational purposes only, not as financial or legal advice.
Sensei Biotherapeutics Inc. has filed an initial statement of beneficial ownership with the Securities and Exchange Commission. The filing lists Christopher Gerry as the beneficial owner, serving as President and PEO of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensei Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002097951-25-000002), on November 24, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
